Champiat, S., Grierson, P., Hsieh, J. C., Ikeda, M., Shao, Y., Yoo, C., Bergamaschi, C., Blanchette, S., Kirby, L., Krotkova, A., Pommier, E., Trissal, M., Goldberg, F., Burman, B., Chan, S. L. (2025). RHEA-1: First-in-human (FIH) study of AZD9793, a first-in-class CD8-guided T cell-engager (TCE) for glypican-3-positive (GPC3+) advanced or metastatic hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps4215